|
Oral
Polio Virus Vaccine ( O.P.V. )
The facilities of Haffkine Bio-Pharmaceutical Corp Ltd. have been inspected by WHO in 1999 and were found to be GMP compliant.
|
| A
trivalent Vaccine used for preventive poliomyelitis in children.
A pink to pale yellow coloured transparent suspension prepared
from 3 types of Polio Viruses (Sabin strains) propogated in
tissue culture.
Available
in Vials of 20 doses.
|
|
|
Active Ingredients : Quantity per dose of (2drops)
Polio Virus (sabin) PMKCC
|
0.1ml
Type 1 106
CCID50
Type 2 105
CCID50
Type 3 105.8
CCID50 |
Packing : 2ml
vial X 50
5ml
vial (10 dose) 50 |
| Category
: Active immunising agent. |
Dosage
: 5 doses orally at an
interval of 4-8 weeks initial
dose to be given immediately after birth.
|
|
|
Rabies Vaccine Human (Neutral Tissue) I.P. B.P.L. Inactivated
|
|
|
It
is useful in preventing human beings from contracting Rabies
caused by the bites of Rabid animals like Dogs, Cats, Monkeys
and wolves. The vaccine is sterile sheep brain suspension, infected with "PARIS FIXED RABIES VIRUS" and inactivated with Betapropiolactone.
Available in vials of 30 ml. |
|
Active Ingredients : Quantity per 5% W/v sheep
Brain suspension with antigenic value Equal to or
more than
|
0.3
|
Packing : 30ml
vial X 10
30ml vial X 100 |
| Category
: For antirabic Treatment which should be started
immediately after a person is bitten , scratched or
licked by a dog or other rabies causing animal. |
Dosage
: The dosage depends upon
the classification of the wound and the age of the bitten
person by SC/IM injection in the deltoid region or abdominal
walls.
|
| Adverse
Drug Reaction : Rare allergic reaction & very
rare cases of neuroparalytic disease. |
|
